Baker Bros. Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.2M | Hold |
|
|||||
|
2025
Q1 | $50.7M | Hold |
|
|||||
|
2024
Q4 | $76.1M | Hold |
|
|||||
|
2024
Q3 | $109M | Hold |
|
|||||
|
2024
Q2 | $86.6M | Hold |
|
|||||
|
2024
Q1 | $76.6M | Buy |
|
|||||
|
2023
Q4 | $56M | Buy |
|
|||||
|
2023
Q3 | $47.3M | Buy |
|
|||||
|
2023
Q2 | $42.9M | Buy |
|
|||||
|
2023
Q1 | $25.1M | Hold |
|
|||||
|
2022
Q4 | $30.3M | Buy |
|
|||||
|
2022
Q3 | $18.1M | Hold |
|
|||||
|
2022
Q2 | $17.3M | Buy |
|
|||||
|
2022
Q1 | $2.85M | Hold |
|
|||||
|
2021
Q4 | $3.96M | Hold |
|
|||||
|
2021
Q3 | $4.48M | Hold |
|
|||||
|
2021
Q2 | $6.96M | Hold |
|
|||||
|
2021
Q1 | $5.07M | Hold |
|
|||||
|
2020
Q4 | $7.43M | Sell |
|
|||||
|
2020
Q3 | $3.56M | Sell |
|
|||||
|
2020
Q2 | $2.54M | Hold |
|
|||||
|
2020
Q1 | $1.84M | Buy |
|